Assessment With CCTA and MRI in Asymptomatic Patients With Type 2 Diabetes for Detection of Unrecognized Myocardial Scar in Subclinical Coronary Atherosclerosis

Xenetix 350 was administered at a dose up to 180 ml, according to the patient's body weight measured on the day of administration.

Dotarem was administered at a dose of 0.1 mmol/kg body weight (0.2 ml/kg body weight)